| Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7 P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu, B Zhang, ... Nature 593 (7857), 130-135, 2021 | 2542 | 2021 |
| Potent neutralizing antibodies directed to multiple epitopes on SARS-CoV-2 spike L Liu, P Wang, MS Nair, J Yu, M Rapp, Q Wang, Y Luo, JFW Chan, V Sahi, ... Nature 584, 450–456, 2020 | 1514* | 2020 |
| Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization P Wang, RG Casner, MS Nair, M Wang, J Yu, G Cerutti, L Liu, PD Kwong, ... Cell host & microbe 29 (5), 747-751. e4, 2021 | 999 | 2021 |
| A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids L Yang, Y Han, BE Nilsson-Payant, V Gupta, P Wang, X Duan, X Tang, ... Cell Stem Cell 27 (1), 125-136, 2020 | 723 | 2020 |
| Identification of SARS-CoV-2 inhibitors using lung and colonic organoids Y Han, X Duan, L Yang, BE Nilsson-Payant, P Wang, F Duan, X Tang, ... Nature 589 (7841), 270-275, 2021 | 618* | 2021 |
| Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite G Cerutti, Y Guo, T Zhou, J Gorman, M Lee, M Rapp, ER Reddem, J Yu, ... Cell host & microbe 29 (5), 819-833. e7, 2021 | 520 | 2021 |
| Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains T Zhou, Y Tsybovsky, J Gorman, M Rapp, G Cerutti, GY Chuang, ... Cell host & microbe 28 (6), 867-879. e5, 2020 | 417* | 2020 |
| Emergence and expansion of SARS-CoV-2 B. 1.526 after identification in New York MK Annavajhala, H Mohri, P Wang, M Nair, JE Zucker, Z Sheng, ... Nature 597 (7878), 703-708, 2021 | 274* | 2021 |
| Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses Y Chen, X Zhao, H Zhou, H Zhu, S Jiang, P Wang Nature Reviews Immunology 23 (3), 189-199, 2023 | 260 | 2023 |
| Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants J Xu, K Xu, S Jung, A Conte, J Lieberman, F Muecksch, JCC Lorenzi, ... Nature 595 (7866), 278-282, 2021 | 212 | 2021 |
| Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells X Qu, P Wang, D Ding, L Li, H Wang, L Ma, X Zhou, S Liu, S Lin, X Wang, ... Nucleic acids research 41 (16), 7771-7782, 2013 | 193 | 2013 |
| Antibody evasion of SARS-CoV-2 Omicron BA. 1, BA. 1.1, BA. 2, and BA. 3 sub-lineages J Ai, X Wang, X He, X Zhao, Y Zhang, Y Jiang, M Li, Y Cui, Y Chen, ... Cell host & microbe 30 (8), 1077-1083. e4, 2022 | 178 | 2022 |
| Defining the risk of SARS-CoV-2 variants on immune protection MM DeGrace, E Ghedin, MB Frieman, F Krammer, A Grifoni, A Alisoltani, ... Nature 605 (7911), 640-652, 2022 | 161 | 2022 |
| Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies X Wang, X Zhao, J Song, J Wu, Y Zhu, M Li, Y Cui, Y Chen, L Yang, J Liu, ... Emerging microbes & infections 11 (1), 477-481, 2022 | 147 | 2022 |
| SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease P Wang, L Liu, MS Nair, MT Yin, Y Luo, Q Wang, T Yuan, K Mori, AG Solis, ... Emerging microbes & infections 9 (1), 2091-2093, 2020 | 143 | 2020 |
| An immuno-cardiac model for macrophage-mediated inflammation in COVID-19 hearts L Yang, Y Han, F Jaffre, BE Nilsson-Payant, Y Bram, P Wang, J Zhu, ... Circulation research 129 (1), 33-46, 2021 | 107* | 2021 |
| Specific reactivation of latent HIV-1 by dCas9-SunTag-VP64-mediated guide RNA targeting the HIV-1 promoter H Ji, Z Jiang, P Lu, L Ma, C Li, H Pan, Z Fu, X Qu, P Wang, J Deng, ... Molecular Therapy 24 (3), 508-521, 2016 | 91 | 2016 |
| The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb P Lu, X Qu, Y Shen, Z Jiang, P Wang, H Zeng, H Ji, J Deng, X Yang, X Li, ... Scientific reports 6 (1), 24100, 2016 | 85 | 2016 |
| SARS-CoV-2 infection causes dopaminergic neuron senescence L Yang, TW Kim, Y Han, MS Nair, O Harschnitz, J Zhu, P Wang, SY Koo, ... Cell Stem Cell 31 (2), 196-211. e6, 2024 | 81 | 2024 |
| A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses P Wang, RG Casner, MS Nair, J Yu, Y Guo, M Wang, JFW Chan, G Cerutti, ... Emerging microbes & infections 11 (1), 147-157, 2022 | 77* | 2022 |
David Hoprofessor of medicine, Columbia universityGeverifieerd e-mailadres voor cumc.columbia.edu
